• Search History (Register)
  • MeSH Browser
Sort by Relevance
Search Results [216 Hits] Selected Records [0 Hits] [Clear]
Year Source Title
2007 National Institute for Health and Care Excellence (NICE) Bortezomib monotherapy for relapsed multiple myeloma. NICE technology appraisal guidance 129
2006 Institute for Clinical Effectiveness and Health Policy (IECS) Main clinical uses of liposomal doxorubicin
2006 HAYES, Inc. High-dose chemotherapy with peripheral stem cell/autologous transplantation, treatment for multiple myeloma
2005 NIHR Horizon Scanning Centre (NIHR HSC) Lenalidomide (Revlimid) for relapsed and/or refractory multiple myeloma - horizon scanning review
2005 Agency for Healthcare Research and Quality (AHRQ) Relative efficacy of oral cancer therapy for Medicare beneficiaries versus currently covered therapy: part 4, thalidomide for multiple myeloma
2004 NIHR Health Technology Assessment programme A systematic review of the role of bisphosphonates in metastatic disease
2004 NIHR Horizon Scanning Centre (NIHR HSC) Bortezomib (Velcade) for relapsed and refractory multiple myeloma - horizon scanning review
2004 HAYES, Inc. In utero fetal surgery
2004 Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Thalidomide for the treatment of multiple myeloma
2003 NIHR Horizon Scanning Centre (NIHR HSC) Bortezomib for multiple myeloma - horizon scanning review
2003 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Epoetin alfa (Eprex®) - For the treatment of anaemia and reduction of transfusion requirements in adult patients receiving chemotherapy for solid tumours, malignant lymphoma or multiple myeloma, and at risk of transfusion as assessed by the patient's general status
2002 Healthcare Insurance Board/ College Voor Zorgverzekeringen (CVZ) Evaluation of additional value of myeloablative chemotherapy / radiotherapy and autologous stem cell transplantation in comparison to chemotherapy in patients with multiple myeloma - primary research
2002 NIHR Horizon Scanning Centre (NIHR HSC) Thalidomide for multiple myeloma - horizon scanning review
2001 Agency for Healthcare Research and Quality (AHRQ) Uses of epoetin for anemia in oncology
2001 Blue Cross Blue Shield Association (BCBS) Nonmyeloablative allogeneic stem-cell transplantation for malignancy
2000 HAYES, Inc. High-dose chemotherapy and radiation therapy followed by allogeneic transplantation for multiple myeloma